amador bioscience-png
Blog_Hero_FullWidth_1600x540@2x

News

May 5, 2023

Amador Bioscience Welcomes Dr. Lorin Roskos as Chief Scientific Officer and President of Quantitative Clinical Pharmacology Amador Bioscience Welcomes Dr. Lorin Roskos as Chief Scientific Officer and President of Quantitative Clinical Pharmacology Pleasanton, Calif., May 5, 2023: Amador Bioscience, a full-service CRO with global expertise in translational research and clinical ...

Mar 7, 2023

Dr. Lorin K. Roskos, Biopharmaceutical Leader and Executive, Joins Amador Bioscience’s Board of Directors Dr. Lorin K. Roskos, Biopharmaceutical Leader and Executive, Joins Amador Bioscience’s Board of Directors Amador Bioscience, a full-service CRO with global expertise in translational research and clinical development, announces the appointment ...

Nov 2, 2022

Amador Bioscience Opens New State-of-the-Art GxP Facility in Maryland Amador Bioscience Opens New State-of-the-Art GxP Facility in Maryland Germantown, Md.: Amador Bioscience, a global translational and clinical research CRO, is pleased to announce the grand opening of its GxP ...

Oct 28, 2022

Amador Bioscience and BIOMED Finalize Collaboration Amador Bioscience and BIOMED Finalize Collaboration Pleasanton, Calif.: Amador Bioscience, a clinical CRO with world-class clinical pharmacology and pharmacometrics expertise, today announced ...

Oct 21, 2022

Amador Bioscience Appoints Dr. Howard Yuwen as Senior Vice President of Global Regulatory Affairs Amador Bioscience Appoints Dr. Howard Yuwen as Senior Vice President of Global Regulatory Affairs Pleasanton, Calif.: Amador Bioscience, a full-service CRO with global expertise in translational research and clinical development, ...

Sep 21, 2022

More Than Four Million Euros for Third-phase Expansion of Netherland-based BioVille More Than Four Million Euros for Third-phase Expansion of Netherland-based BioVille Thursday, September 8, 2022 at 3:25 a.m.  

Sep 12, 2022

Amador Bioscience and Ann Arbor Pharmacometrics Group Further Align to Take End-to-End Drug Development Into the Future Amador Bioscience and Ann Arbor Pharmacometrics Group Further Align to Take End-to-End Drug Development Into the Future In December of 2021, Ann Arbor Pharmacometrics Group (A2PG) joined forces with Amador Bioscience to strengthen its global leadership in ...

Mar 10, 2022

Amador Bioscience Establishes Clinical Division in Hangzhou Amador Bioscience Establishes Clinical Division in Hangzhou On March 10, 2022, Amador Bioscience announced the establishment of a new clinical business unit in Hangzhou. Patrick Hu, MD, was appointed ...

Jan 10, 2022

Dr. Meina Liang Joins Amador Bioscience as Chief Technology Officer Dr. Meina Liang Joins Amador Bioscience as Chief Technology Officer On January 10, 2022, Amador Bioscience announced the appointment of Dr. Meina Liang, PhD, a world-renowned innovative drug R&D and ...

Dec 31, 2021

Translational Science and Clinical Pharmacology CRO, Amador Bioscience, Announces the Completion of Over $60 Million in Series B+ Financing Translational Science and Clinical Pharmacology CRO, Amador Bioscience, Announces the Completion of Over $60 Million in Series B+ Financing The new round of financing was led by Heyu Capital (MSA), and the existing shareholders Sequoia China, Hillhouse Ventures, and Kaifeng ...

Dec 24, 2021

Amador Bioscience Acquires Ann Arbor Pharmacometrics Group (A2PG) Amador Bioscience Acquires Ann Arbor Pharmacometrics Group (A2PG) Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed the acquisition of ...

Nov 28, 2021

Amador Bioscience Expands to Belgium Amador Bioscience Expands to Belgium The Biopharmaceutical Ecosystem Development Seminar jointly organized by the Provincial Government of Limburg, Belgium, Amador Bioscience ...

Nov 4, 2021

Strategic Cooperation Agreement Between Amador Bioscience and Belgian Government Strategic Cooperation Agreement Between Amador Bioscience and Belgian Government Recently, Amador Biotech signed a strategic cooperation with the Belgian government. Tom Vandeput, Deputy Governor of Limburg Province in ...

Don't miss our latest news!

Join our mailing list.